Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Dexcom

Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids

Shares of Dexcom, Tandem Diabetes and Insulet skidded Tuesday on a proposal that would cut Medicare reimbursements for wearable diabetes tech.

Investors Business Daily

2 ‘Strong Buy’ Stocks That the MAHA Movement AND Wall Street Love

Policies associated with the MAHA movement could boost these two stocks significantly.

Barchart

Diabetics at Risk: FDA Issues Highest-Level Recall on 2M Dexcom Devices Over 'Deadly Fault'

The FDA has recalled 2 million Dexcom glucose monitors due to a serious safety risk. Learn how diabetic patients should act immediately to protect their health.

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

DexCom Stock: Is DXCM Underperforming the Health Care Sector?

DexCom has underperformed the Health Care sector over the past year, but analysts are highly optimistic about the stock’s prospects.

Barchart

Stocks With Rising Relative Strength: DexCom

A Relative Strength Rating upgrade for DexCom shows improving technical performance. Will it continue?

Investors Business Daily

Garmin has patented long-term blood glucose tracking; here's how it'd work

Garmin watches already pair with Dexcom for indirect blood glucose monitoring. This patent shows how Garmin watches could directly help diabetics.

Android Central

Do Wall Street Analysts Like DexCom Stock?

Despite trailing the broader market over the past year, DexCom continues to attract strong optimism from Wall Street analysts, who maintain a highly positive outlook on the stock's long-term potential.

Barchart

Read news from The Economist, FT, and more,
with one subscription

DexCom Stock: Earnings Beat and New Market Access Drive Bull Case

Dexcom's strong quarterly performance and innovative product pipeline signal continued leadership and expansion within the evolving diabetes technology market.

MarketBeat

Oura brings AI-powered meals and glucose tracking to the US

Oura launches two metabolic features within the Oura app that help users track their meals, rise in glucose levels to manage their eating habits.

Android Central

Dexcom Surges After FDA Clears Its Next-Generation Diabetes Device

Dexcom stock surged Thursday after the Food and Drug Administration cleared its newest diabetes device for an extended 15-day period.

Investors Business Daily

Is DexCom Stock Underperforming the Dow?

DexCom significantly underperformed the Dow over the past year, yet analysts remain strongly bullish on the stock’s long term prospects.

Barchart

Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't Worried

Dexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities in the U.S.

Investors Business Daily

DexCom Stock Outlook: Is Wall Street Bullish or Bearish?

Although DexCom has significantly lagged behind the broader market over the past year, Wall Street analysts remain strongly optimistic about the stock's prospects.

Barchart

Dexcom Stock Makes A Recovery After Its Fourth-Quarter Fumble

Dexcom stock stock recovered Friday after the diabetes devices maker missed fourth-quarter profit expectations.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

What to Expect From DexCom's Q4 2024 Earnings Report

DexCom is gearing up to release its fourth-quarter earnings next month, and analysts forecast single-digit profit growth.

Android Central

The Oura Ring is about giving your body a voice, says Oura CEO

The Oura Ring 4 set a standard in the smart ring industry, and its CEO is excited for the future to make Oura the ring connected to our health.

Barchart

Is DexCom Stock Underperforming the Nasdaq?

Despite DexCom's lagging performance relative to the Nasdaq Composite over the past year, Wall Street analysts maintain a strong bullish outlook on the stock's prospects.

Benzinga

Key Takeaways From DexCom Analyst Ratings

DexCom (NASDAQ:DXCM) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

Get all your
news in one place.

100’s of premium titles.
One news app.

TechRadar

The Stelo glucose biosensor changed the way I manage my diabetes - I tested it for two weeks, and here's how it went

The Stelo glucose biosensor is more affordable and accessible, but how well does it work for diabetics?

International Business Times

Dexcom Glucose Data To Be Integrated With ŌURA Rings

Dexcom and ŌURA have partnered to integrate Dexcom's glucose biosensing feature with the ŌURA Ring's health metrics to help improve consumers' metabolic health.

TechRadar

Your Oura Ring will be able to show you glucose readings in 2025 – thanks to Dexcom integration

The company is now valued at over $5 billion

Barchart

Are Wall Street Analysts Predicting DexCom Stock Will Climb or Sink?

Despite DexCom’s underperformance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Evening Standard

Nick Jonas wants to 'take bigger risks' as he reflects on 'wild' Jonas Brothers milestone

EXCLUSIVE The singer-songwriter and actor has crammed a lot into his 32 years of life and the ‘incredibly ambitious and driven’ star is determined there will be a lot more to come

Investors Business Daily

Dexcom Pares Steep Losses Despite A Key Exec Departure Amid Stelo Launch

Dexcom stock closed in the red on Friday after the diabetes devices player beat third-quarter expectations and kept its outlook.

The Conversation

Glucose monitors for diabetes have finally been funded – but a chronic workforce shortage will limit the benefits

Pharmac’s decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live with type 1 diabetes in Aotearoa New Zealand is good news.

1 2 3 4 5

People

Margaret Kaczor Andrew

12 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Investor Business Daily

the Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.